Last reviewed · How we verify
Anaerobic Tubo-Ovarian Abscess
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anaerobic Tubo-Ovarian Abscess patent landscape — cliff calendar, originator estates, attackable patents
- Anaerobic Tubo-Ovarian Abscess treatment landscape brief
- Anaerobic Tubo-Ovarian Abscess treatment updates RSS
Frequently asked questions about Anaerobic Tubo-Ovarian Abscess
What drugs treat Anaerobic Tubo-Ovarian Abscess?
Tracked treatments include Cleocin T, Cleocin.
What is the treatment for Anaerobic Tubo-Ovarian Abscess?
Standard treatment for Anaerobic Tubo-Ovarian Abscess includes Cleocin T, Cleocin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Anaerobic Tubo-Ovarian Abscess patent cliff · Anaerobic Tubo-Ovarian Abscess CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing